Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study

BACKGROUND: Immune-evading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging continuously. The clinical effectiveness of monoclonal antibody agents that exhibit decreased in vitro activity against SARS-CoV-2 variants needs to be elucidated. METHODS: A nationwide, mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Haein, Jang, Young Rock, Lee, Ji Yeon, Ko, Jae-Hoon, Lee, Jee Young, Cho, Seongcheol, Lee, Yong Dae, Song, Junghoon, Hyun, Miri, Kim, Hyun Ah, Hwang, Soyoon, Ryou, Sangmi, Na, Yoo Jin, Lee, Joo-Yeon, Lee, Changhee, Lee, Nan Young, Shin, Seunghwan, Kwon, Ki Tae, Kim, Jin Yong, Peck, Kyong Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225538/
https://www.ncbi.nlm.nih.gov/pubmed/37256107
http://dx.doi.org/10.3389/fcimb.2023.1192512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225538/
https://www.ncbi.nlm.nih.gov/pubmed/37256107
http://dx.doi.org/10.3389/fcimb.2023.1192512

Ejemplares similares